HCM Q4 2017 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$113M+102.0% YoY

Gross Profit

$28M24.6% margin

Operating Income

-$37M-32.6% margin

Net Income

-$28M-24.8% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+96.6%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$30M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$598M

Total Liabilities

$113M

Stockholders' Equity

$462M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$113M	$56M	+102.0%
Gross Profit	$28M	-$5M	+656.0%
Operating Income	-$37M	-$15M	-138.9%
Net Income	-$28M	$6M	-600.5%